Reuben McGregor
banner
rhcmcg.bsky.social
Reuben McGregor
@rhcmcg.bsky.social
New paper out in JCI Insight:
PhIP-Seq uncovers marked heterogeneity in Acute Rheumatic Fever Autoantibodies.

ARF is a serious sequela of Strep A infection. While autoantibodies are known to drive pathogenesis, the specific human protein targets remain unclear.

Link: doi.org/10.1172/jci....
1/5
December 7, 2025 at 8:53 PM
Reposted by Reuben McGregor
This deep dive into the clinical phenotype of rheumatic fever highlights extreme diversity in presenting symptoms. An important observation from the START study, and highlights why better diagnostic tests are needed 🧪 @annapralph.bsky.social @rhcmcg.bsky.social

bmjopen.bmj.com/content/15/7...
July 22, 2025 at 5:44 AM
Reposted by Reuben McGregor
Following relaxation of #COVID19 restrictions surges in infections from respiratory pathogens like RSV and #StrepA have been seen in many countries including Aotearoa New Zealand.
Did waning immunity contribute? We explored this concept in our latest work, see 🧵 academic.oup.com/jid/advance-...
Decline of antibodies to major viral and bacterial respiratory pathogens during the COVID-19 pandemic
Antibodies to respiratory syncytial virus and Group A Streptococcus waned significantly in a longitudinal cohort throughout the pandemic. This waning may h
academic.oup.com
December 15, 2024 at 10:17 PM
Reposted by Reuben McGregor
Finally jumping into 🦋 - and what better way to do than highlighting this super thread. Wonderful to have been involved in this study with our Strep A friends across the Tasman
🎉 I'm a #newPI , and I'm so excited to share our new paper out in Nature Comms today! 🧵
rdcu.be/d2gBV
Quick intro for the new followers:
I'm from Monash Uni in Melbourne, and we study T and B cell responses to viruses, bacteria & parasites with the goal of improving vaccines. #ImmunoSky #MicroSky
December 4, 2024 at 10:48 AM
Reposted by Reuben McGregor
🎉 I'm a #newPI , and I'm so excited to share our new paper out in Nature Comms today! 🧵
rdcu.be/d2gBV
Quick intro for the new followers:
I'm from Monash Uni in Melbourne, and we study T and B cell responses to viruses, bacteria & parasites with the goal of improving vaccines. #ImmunoSky #MicroSky
December 3, 2024 at 1:11 PM